Identification of antibiotic stress-inducible promoters: A systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery

Genome Research

Volumn 14, Issue 1, 2004, Pages 90-98

  Fischer, Hans Peter ^a   Brunner, Nina A ^b   Wieland, Bernd ^b   Paquette, Jesse ^a   Macko, Ludwig ^a   Ziegelbauer, Karl ^b   Freiberg, Christoph ^b  

^a GENEDATA AG   (Switzerland)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINONIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CERULENIN; COMPLEMENTARY DNA; METICILLIN; MONENSIN; NOVOBIOCIN; POLYMYXIN B; TRANSCRIPTION FACTOR; TRICLOSAN; TRIMETHOPRIM; VANCOMYCIN;

ALGORITHM; ANALYTIC METHOD; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BINDING SITE; CELL ASSAY; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; EXPERIMENTAL DESIGN; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

5' FLANKING REGION; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACILLUS; BINDING SITES; CELL EXTRACTS; CHROMOSOME MAPPING; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, BACTERIAL; FATTY ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; GENES, REPORTER; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; OPERON; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 0347766000     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.1275704     Document Type: Article

References (41)

1. Alksne, L.E., Burgio, P., Hu, W., Feld, B., Singh, M.P., Tuckman, M., Petersen, P.J., Labthavikul, P., McGlynn, M., Barbieri, L., et al. 2000. Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system. Antimicrob. Agents Chemother. 44: 1418-1427.
2. Arantes, O. and Lereclus, D. 1991. Construction of cloning vectors for Bacillus thuringiensis. Gene 108: 115-119.
3. Bianchi, A.A. and Baneyx, F. 1999. Stress responses as a tool to detect and characterize the mode of action of antibacterial agents. Appl. Environ. Microbiol. 65: 5023-5027.
4. Breithaupt, H. 1999. The new antibiotics. Nat. Biotechnol. 17: 1165-1169.
5. Campbell, J.W. and Cronan Jr., J.E. 2001. Bacterial fatty acid biosynthesis: Targets for antibacterial drug discovery. Annu. Rev. Microbiol. 55: 305-332.
6. Choi, K.H., Heath, R.J., and Rock, C.O. 2000. β-Ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis. J. Bacteriol. 182: 365-370.
7. Chopra, I., Hesse, L., and O'Neill, A.J. 2002. Exploiting current understanding of antibiotic action for discovery of new drugs. J. Appl. Microbiol. 92 Suppl: 4S-15S.
8. DeVito, J.A., Mills, J.A., Liu, V.G., Agarwal, A., Sizemore, C.F., Yao, Z., Stoughton, D.M., Cappiello, M.G., Barbosa, M.D., Foster, L.A., et al. 2002. An array of target-specific screening strains for antibacterial discovery. Nat. Biotechnol. 20: 478-483.
9. Fischer, H.P. 2001. The impact of expression profiling technologies on antimicrobial target identification and validation. Drug Discov. Today 6: 1149-1150.
10. Forsyth, R.A., Haselbeck, R.J., Ohlsen, K.L., Yamamoto, R.T., Xu, H., Trawick, J.D., Wall, D., Wang, L., Brown-Driver, V., Froelich, J.M., et al. 2002. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol. Microbiol. 43: 1387-1400.
11. Freiberg, C. and Brunner, N.A. 2002. Genome-wide mRNA profiling: Impact on compound evaluation and target identification in anti-bacterial research. Targets 1: 20-29.
12. Gerdes, S.Y., Scholle, M.D., D'Souza, M., Bernal, A., Baev, M.V., Farrell, M., Kurnasov, O.V., Daugherty, M.D., Mseeh, F., Polanuyer, B.M., et al. 2002. From genetic footprinting to antimicrobial drug targets: Examples in cofactor biosynthetic pathways. J. Bacteriol. 184: 4555-4572.
13. Gmuender, H., Kuratli, K., Di Padova, K., Gray, C.P., Keck, W., and Evers, S. 2001. Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: Combined transcription and translation analysis. Genome Res. 11: 28-42.
14. Goffin, C. and Ghuysen, J.M. 1998. Multimodular penicillin-binding proteins: An enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62: 1079-1093.
15. Goryachev, A.B., Macgregor, P.F., and Edwards, A.M. 2001. Unfolding of microarray data. J. Comput. Biol. 8: 443-461.
16. Gray, C.P. and Keck, W. 1999. Bacterial targets and antibiotics: Genome-based drug discovery. Cell Mol. Life Sci. 56: 779-787.
17. Heath, R.J., Yu, Y.T., Shapiro, M.A., Olson, E., and Rock, C.O. 1998. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J. Biol. Chem. 273: 30316-30320.
18. Heath, R.J., White, S.W., and Rock, C.O. 2001. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40: 467-497.
19. Huffman, J.L. and Brennan, R.G. 2002. Prokaryotic transcription regulators: More than just the helix-turn-helix motif. Curr. Opin. Struct. Biol. 12: 98-106.
20. Ji, Y., Zhang, B., Van Horn, S.F., Warren, P., Woodnutt, G., Burnham, M.K., and Rosenberg, M. 2001. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293: 2266-2269.
21. Kauppinen, S., Siggaard-Andersen, M., and von Wettstein-Knowles, P. 1988. β-Ketoacyl-ACP synthase I of Escherichia coli: Nucleotide sequence of the fabB gene and identification of the cerulenin binding residue. Carlsbery Res. Commun. 53: 357-370.
22. Kunst, F., Ogasawara, N., Moszer, I., Albertini, A.M., Alloni, G., Azevedo, V., Bertero, M.G., Bessieres, P., Bolotin, A., Borchert, S., et al. 1997. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390: 249-256.
23. Lawrence, C.E., Altschul, S.F., Boguski, M.S., Liu, J.S., Neuwald, A.F., and Wootton, J.C. 1993. Detecting subtle sequence signals: A Gibbs sampling strategy for multiple alignment. Science 262: 208-214.
24. McCue, L., Thompson, W., Carmack, C., Ryan, M.P., Liu, J.S., Derbyshire, V., and Lawrence, C.E. 2001. Phylogenetic footprinting of transcription factor binding sites in proteobacterial genomes. Nucleic Acids Res. 29: 774-782.
25. McDevitt, D., Payne, D.J., Holmes, D.J., and Rosenberg, M. 2002. Novel targets for the future development of antibacterial agents. J. Appl. Microbiol. 92 Suppl: 28S-34S.
26. McGuire, A.M., Hughes, J.D., and Church, G.M. 2000. Conservation of DNA regulatory motifs and discovery of new motifs in microbial genomes. Genome Res. 10: 744-757.
27. Mironov, A.A., Koonin, E.V., Roytberg, M.A., and Gelfand, M.S. 1999. Computer analysis of transcription regulatory patterns in completely sequenced bacterial genomes. Nucleic Acids Res. 27: 2981-2989.
28. Moche, M., Schneider, G., Edwards, P., Dehesh, K., and Lindqvist, Y. 1999. Structure of the complex between the antibiotic cerulenin and its target, β-ketoacyl-acyl carrier protein synthase. J. Biol. Chem. 274: 6031-6034.
29. Payne, D.J., Warren, P.V., Holmes, D.J., Ji, Y., and Lonsdale, J.T. 2001. Bacterial fatty-acid biosynthesis: A genomics-driven target for antibacterial drug discovery. Drug Discov. Today 6: 537-544.
30. Payne, D.J., Miller, W.H., Berry, V., Brosky, J., Burgess, W.J., Chen, E., DeWolf Jr., W.E., Fosberry, A.P., Greenwood, R., Head, M.S., et al. 2002. Discovery of a novel and potent class of FabI-directed antibacterial agents. Antimicrob. Agents Chemother. 46: 3118-3124.
31. Riddell, F.G. 2002. Structure, conformation, and mechanism in the membrane transport of alkali metal ions by ionophoric antibiotics. Chirality 14: 121-125.
32. Rosamond, J. and Allsop, A. 2000. Harnessing the power of the genome in the search for new antibiotics. Science 287: 1973-1976.
33. Sabatti, C., Rohlin, L., Oh, M.K., and Liao, J.C. 2002. Co-expression pattern from DNA microarray experiments as a tool for operon prediction. Nucleic Acids Res. 30: 2886-2893.
34. Schujman, G.E., Choi, K.H., Altabe, S., Rock, C.O., and de Mendoza, D. 2001. Response of Bacillus subtilis to cerulenin and acquisition of resistance. J. Bacteriol. 183: 3032-3040.
35. Scott, M.G., Gold, M.R., and Hancock, R.E. 1999. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect. Immun. 67: 6445-6453.
36. Selinger, D.W., Saxena, R.M., Cheung, K.J., Church, G.M., and Rosenow, C. 2003. Global RNA half-life analysis in Escherichia coli reveals positional patterns of transcript degradation. Genome Res. 13: 216-223.
37. Shapiro, E. and Baneyx, F. 2002. Stress-based identification and classification of antibacterial agents: Second-generation Escherichia coli reporter strains and optimization of detection. Antimicrob. Agents Chemother. 46: 2490-2497.
38. Stulke,J ., Hanschke, R., and Hecker, M. 1993. Temporal activation of β-glucanase synthesis in Bacillus subtilis is mediated by the GTP pool. J. Gen. Microbiol. 139 (Pt 9): 2041-2045.
39. Sun, D., Cohen, S., Mani, N., Murphy, C., and Rothstein, D.M. 2002. A pathway-specific cell based screening system to detect bacterial cell wall inhibitors. J. Antibiot. (Tokyo) 55: 279-287.
40. Whiteley, M., Bangera, M.G., Bumgarner, R.E., Parsek, M.R., Teitzel, G.M., Lory, S., and Greenberg, E.P. 2001. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413: 860-864.
41. Wilson, M., DeRisi, J., Kristensen, H.H., Imboden, P., Rane, S., Brown, P.O., and Schoolnik, G.K. 1999. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridisation. Proc. Natl. Acad. Sci. 96: 12833-12838.